Sarissa Capital Offshore Master Fund LP's Net Worth
$44.1 Million
Who is Sarissa Capital Offshore Master Fund LP?
Sarissa Capital Offshore Master Fund LP has an estimated net worth of $44.1 Million. This is based on reported shares across multiple companies, which include VIVUS INC, APRICUS BIOSCIENCES, INC., Iterum Therapeutics plc, and Regulus Therapeutics Inc..
SEC CIK
Sarissa Capital Offshore Master Fund LP's CIK is 0001577530
Past Insider Trading and Trends
2016 was Sarissa Capital Offshore Master Fund LP's most active year for acquiring shares with 4 total transactions. Sarissa Capital Offshore Master Fund LP's most active month to acquire stocks was the month of February. 2020 was Sarissa Capital Offshore Master Fund LP's most active year for disposing of shares, totalling 3 transactions. Sarissa Capital Offshore Master Fund LP's most active month to dispose stocks was the month of January. 2016 saw Sarissa Capital Offshore Master Fund LP paying a total of $7,000,001.36 for 11,931,820 shares, this is the most they've acquired in one year. In 2021 Sarissa Capital Offshore Master Fund LP cashed out on 35,619,949 shares for a total of $50,007,284.23, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Iterum Therapeutics plc (ITRM) Snapshot price: $1.7299
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.43 | -$50,007,284.23 | 20.62M |
Feb 11 - Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.37
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIVUS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APRICUS BIOSCIENCES, INC. (SEEL) Snapshot price: $0.7365
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
| +0.42% | 6.1K |
$1.63 | $9,949.52 | 1.45M |
Aug 31
| |||
Form 4
| +84.89% | 6.65M |
$0.88 | $5,850,000.64 | 14.48M |
Mar 3
| |||
Form 4
| +20.03% | 1.31M |
$0.88 | $1,150,000.72 | 7.83M |
Jan 12
| |||
| No matching records found | |||||||||